208 related articles for article (PubMed ID: 1931093)
21. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation.
Kuitunen AH; Heikkilä LJ; Salmenperä MT
Ann Thorac Surg; 1997 Feb; 63(2):438-44. PubMed ID: 9033316
[TBL] [Abstract][Full Text] [Related]
22. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
23. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Duraflo II heparin immobilized cardiopulmonary bypass circuits.
Tong SD; Rolfs MR; Hsu LC
ASAIO Trans; 1990; 36(3):M654-6. PubMed ID: 2252775
[TBL] [Abstract][Full Text] [Related]
25. Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets.
Mirow N; Brinkmann T; Minami K; Tenderich G; Schulte-Eistrup S; Kleesiek K; Körfer R
J Cardiovasc Surg (Torino); 2001 Oct; 42(5):579-85. PubMed ID: 11562580
[TBL] [Abstract][Full Text] [Related]
26. Cardiopulmonary bypass with a surface-heparinized extracorporeal perfusion system.
Palatianos GM; Dewanjee MK; Kapadvanjwala M; Novak S; Sfakianakis GN; Kaiser GA
ASAIO Trans; 1990; 36(3):M476-9. PubMed ID: 2252729
[TBL] [Abstract][Full Text] [Related]
27. Heparin-coated oxygenators significantly reduce contact system activation in an in vitro cardiopulmonary bypass model.
Wendel HP; Heller W; Gallimore MJ; Hoffmeister HE
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):673-8. PubMed ID: 7865672
[TBL] [Abstract][Full Text] [Related]
28. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
[TBL] [Abstract][Full Text] [Related]
29. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
Hatori N; Yoshizu H; Haga Y; Kusama Y; Takeshima S; Segawa D; Tanaka S
Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
[TBL] [Abstract][Full Text] [Related]
30. Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery.
Hoel TN; Videm V; Baksaas ST; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 2004 May; 19(3):177-84. PubMed ID: 15298426
[TBL] [Abstract][Full Text] [Related]
31. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: similar clinical results and minor biochemical differences.
Wimmer-Greinecker G; Matheis G; Martens S; Oremek G; Abdel-Rahman U; Moritz A
Eur J Cardiothorac Surg; 1999 Aug; 16(2):211-7. PubMed ID: 10485423
[TBL] [Abstract][Full Text] [Related]
32. Comparison of polymethoxyethylacrylate-coated circuits with leukocyte filtration and reduced heparinization protocol on heparin-bonded circuits in different risk cohorts.
Gunaydin S; McCusker K; Vijay V; Isbir S; Sari T; Onur MA; Gurpinar A; Sezgin A; Sargon MF; Tezcaner T; Zorlutuna Y
Perfusion; 2006 Nov; 21(6):329-42. PubMed ID: 17312857
[TBL] [Abstract][Full Text] [Related]
33. [Experimental study on heparin-free cardiopulmonary bypass using nafamostat mesilate (FUT-175) and heparin-coated circuit].
Takano H; Miyamoto Y; Kaneko M; Matsuwaka R; Kuratani T; Amemiya A; Nakano S; Matsuda H
Nihon Kyobu Geka Gakkai Zasshi; 1993 Nov; 41(11):2166-73. PubMed ID: 8283086
[TBL] [Abstract][Full Text] [Related]
34. Biocompatibility of heparin-coated extracorporeal bypass circuits: new heparin bonded bioline system.
Tayama E; Hayashida N; Akasu K; Kosuga T; Fukunaga S; Akashi H; Kawara T; Aoyagi S
Artif Organs; 2000 Aug; 24(8):618-23. PubMed ID: 10971248
[TBL] [Abstract][Full Text] [Related]
35. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
Nishida H; Aomi S; Tomizawa Y; Endo M; Koyanagi H; Nojiri C; Oshiyama H; Kido T; Yokoyama K
Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
[TBL] [Abstract][Full Text] [Related]
36. Heparinless cardiopulmonary bypass with argatroban in dogs.
Rikitake K; Okazaki Y; Naito K; Ohtsubo S; Natsuaki M; Itoh T
Eur J Cardiothorac Surg; 2004 May; 25(5):819-24. PubMed ID: 15082288
[TBL] [Abstract][Full Text] [Related]
37. Trillium coating of cardiopulmonary bypass circuits improves biocompatibility.
Tevaearai HT; Mueller XM; Seigneul I; Burki M; Horisberger J; Stumpe F; Von Segesser LK
Int J Artif Organs; 1999 Sep; 22(9):629-34. PubMed ID: 10532432
[TBL] [Abstract][Full Text] [Related]
38. Closed, phosphorylcholine-coated circuit and reduction of systemic heparinization for cardiopulmonary bypass: the intraoperative ECMO concept.
Ranucci M; Pazzaglia A; Isgrò G; Cazzaniga A; Ditta A; Boncilli A; Cotza M; Carboni G; Brozzi S; Bonifazi C
Int J Artif Organs; 2002 Sep; 25(9):875-81. PubMed ID: 12403404
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of heparin-coated circuits with full heparin dose strategy.
Sinci V; Kalaycioglu S; Gunaydin S; Imren Y; Gokgoz L; Soncul H; Ersoz A
Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761
[TBL] [Abstract][Full Text] [Related]
40. Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose.
Borowiec J; Thelin S; Bagge L; Hultman J; Hansson HE
Scand J Thorac Cardiovasc Surg; 1992; 26(3):177-85. PubMed ID: 1287831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
